Abstract CN21
Background
Screening plays a key role in preventing incidence of cervical cancer. In Ireland, the incidence and screening participation rates are not evenly distributed across the population, and evidence is limited. To provide and equitable service, it is important to understand who is and is not attending screening and why. This study explored the perceptions of expert stakeholders on cervical cancer screening attendance and accessibility in Ireland.
Methods
Semi-structured interviews were conducted with 12 healthcare professionals, policymakers and academics to explore their expert views on cervical screening accessibility and attendance in Ireland. Interviews were conducted online in 2022. Reflexive thematic analysis was used inductively to generate themes, supported by NVivo.
Results
Three themes were developed from the interview data: Getting the right information out the right way, Acceptability and accessibility of screening, and trying to identify and reach the non-attenders. Participants felt public knowledge of cervical screening and Human Papilloma Virus was low and the communication of this information needed to align better with sources that women engage with. Accessibility and acceptability of screening was thought to be dependent on individual, cultural and structural and service factors. Identifying and reaching non-attenders was considered important by participants but community outreach and public engagement could enhance understanding and address the challenges of non-attendance.
Conclusions
Nurses have a significant opportunity to support uptake and engagement with screening. Nurses are often the first point of contact to provide information regarding health promotion and are therefore well positioned to provide education and support which can address the barriers to screening engagement. Community engagement could support understanding of the distribution of participation and awareness of screening and enhance supports for women to make informed decisions about engagement with cervical screening.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Irish Cancer Society.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
CN49 - Nurse–patient sexual health communication in gynecological cancer follow-up: A qualitative study from nurses’ perspectives
Presenter: Anita Paulsen
Session: Poster session 25
Resources:
Abstract
CN50 - Patient-reported outcome measures and supportive care need assessment in patients in a slovenian tertiary oncology centre
Presenter: Majda Causevic
Session: Poster session 25
Resources:
Abstract
CN51 - Psychometric properties of the Turkish version of the nurse spiritual therapeutic scale for oncology patients and caregivers
Presenter: Remziye Semerci
Session: Poster session 25
Resources:
Abstract
CN52 - Role of translational oncology research nurse (TORN) in improving patients (pts) adherence to microbiome research projects
Presenter: Ariadna Garcia Rodriguez
Session: Poster session 25
Resources:
Abstract
CN53 - Sexual function in survivors of hematological malignancy and autologous hematopoietic stem cell transplantation
Presenter: Ioanna Tsatsou
Session: Poster session 25
Resources:
Abstract
CN54 - Sexual health in women with breast cancer undergoing hormonal treatment
Presenter: Cristina Tebar
Session: Poster session 25
Resources:
Abstract
CN55 - The impact of psychosocial support on the overall health of cancer patients in the COVID-19 era
Presenter: Gianluca Catania
Session: Poster session 25
Resources:
Abstract
CN56 - Well-being and healthcare concerns of patients with advanced renal cell carcinoma: The RCC PROMs international survey
Presenter: Grigorios Kotronoulas
Session: Poster session 25
Resources:
Abstract
CN57 - Patients, informal caregivers and healthcare professionals experience in adoptive cell therapies: An experience-based co-design study (EBCD-ACT)
Presenter: Canova Canova
Session: Poster session 25
Resources:
Abstract
CN64 - Assessment of depression among lung cancer patients with type 2 diabetes using centre for epidemiologic studies depression scale (CES-D)
Presenter: Maria Lavdaniti
Session: Poster session 25
Resources:
Abstract